Brandon Poe

Chief Financial Officer at BioStem Technologies (OTC: BSEM)

Brandon Poe currently serves as Chief Financial Officer and Member of the Board of Directors at BioStem Technologies, where Brandon also chairs the Audit Committee. Previous experience includes roles as Chief Financial Officer at Midi Health, Jumpcode Genomics, and Genome Medical, Inc. Brandon Poe held multiple Vice President positions at Illumina, overseeing finance in product development, clinical genomics, and enterprise FP&A, as well as serving as Chief Financial Officer at Sotera Wireless, Inc. and Vice President of Finance at Biosite Incorporated. Early in the career, roles included Senior Manager of Financial Planning and Analysis at Gateway, Inc., and Senior Director of Financial Planning & Analysis at Continental Airlines. Brandon Poe holds an MBA in Finance from The University of Chicago Booth School of Business and a BSBA in Business Administration and Management from Bucknell University.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


BioStem Technologies (OTC: BSEM)

BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.


Employees

11-50

Links